163 related articles for article (PubMed ID: 32379447)
1. Validating the 1,2-Difluoro Motif As a Hybrid Bioisostere of CF
Erdeljac N; Thiehoff C; Jumde RP; Daniliuc CG; Höppner S; Faust A; Hirsch AKH; Gilmour R
J Med Chem; 2020 Jun; 63(11):6225-6237. PubMed ID: 32379447
[TBL] [Abstract][Full Text] [Related]
2. Structural basis of matrix metalloproteinases and tissue inhibitors of metalloproteinases.
Maskos K; Bode W
Mol Biotechnol; 2003 Nov; 25(3):241-66. PubMed ID: 14668538
[TBL] [Abstract][Full Text] [Related]
3. Understanding the binding of inhibitors of matrix metalloproteinases by molecular docking, quantum mechanical calculations, molecular dynamics simulations, and a MMGBSA/MMBappl study.
Singh T; Adekoya OA; Jayaram B
Mol Biosyst; 2015 Apr; 11(4):1041-51. PubMed ID: 25611160
[TBL] [Abstract][Full Text] [Related]
4. Peptide-based selective inhibitors of matrix metalloproteinase-mediated activities.
Ndinguri MW; Bhowmick M; Tokmina-Roszyk D; Robichaud TK; Fields GB
Molecules; 2012 Nov; 17(12):14230-48. PubMed ID: 23201642
[TBL] [Abstract][Full Text] [Related]
5. Design and Structural Evolution of Matrix Metalloproteinase Inhibitors.
Fischer T; Senn N; Riedl R
Chemistry; 2019 Jun; 25(34):7960-7980. PubMed ID: 30720221
[TBL] [Abstract][Full Text] [Related]
6. Structure-based molecular insights into matrix metalloproteinase inhibitors in cancer treatments.
Lin H; Xu P; Huang M
Future Med Chem; 2022 Jan; 14(1):35-51. PubMed ID: 34779649
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory Antibodies Designed for Matrix Metalloproteinase Modulation.
Fischer T; Riedl R
Molecules; 2019 Jun; 24(12):. PubMed ID: 31216704
[TBL] [Abstract][Full Text] [Related]
8. Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.
Tauro M; Laghezza A; Loiodice F; Agamennone M; Campestre C; Tortorella P
Bioorg Med Chem; 2013 Nov; 21(21):6456-65. PubMed ID: 24071448
[TBL] [Abstract][Full Text] [Related]
9. Structural basis of the matrix metalloproteinases and their physiological inhibitors, the tissue inhibitors of metalloproteinases.
Bode W; Maskos K
Biol Chem; 2003 Jun; 384(6):863-72. PubMed ID: 12887053
[TBL] [Abstract][Full Text] [Related]
10. Identification of Broad-Spectrum MMP Inhibitors by Virtual Screening.
Gimeno A; Cuffaro D; Nuti E; Ojeda-Montes MJ; Beltrán-Debón R; Mulero M; Rossello A; Pujadas G; Garcia-Vallvé S
Molecules; 2021 Jul; 26(15):. PubMed ID: 34361703
[TBL] [Abstract][Full Text] [Related]
11. An integrated structure- and pharmacophore-based MMP-12 virtual screening.
Ramezani M; Shamsara J
Mol Divers; 2018 May; 22(2):383-395. PubMed ID: 29423648
[TBL] [Abstract][Full Text] [Related]
12. MMP inhibition by barbiturate homodimers.
Wang J; Radomski MW; Medina C; Gilmer JF
Bioorg Med Chem Lett; 2013 Jan; 23(2):444-7. PubMed ID: 23246356
[TBL] [Abstract][Full Text] [Related]
13. Identification of selective MMP-9 inhibitors through multiple e-pharmacophore, ligand-based pharmacophore, molecular docking, and density functional theory approaches.
Jana S; Singh SK
J Biomol Struct Dyn; 2019 Mar; 37(4):944-965. PubMed ID: 29475408
[TBL] [Abstract][Full Text] [Related]
14. Structural basis of matrix metalloproteinase function.
Bode W
Biochem Soc Symp; 2003; (70):1-14. PubMed ID: 14587278
[TBL] [Abstract][Full Text] [Related]
15. Encounter with unexpected collagenase-1 selective inhibitor: switchover of inhibitor binding pocket induced by fluorine atom.
Sawa M; Kondo H; Nishimura S
Bioorg Med Chem Lett; 2002 Feb; 12(4):581-4. PubMed ID: 11844676
[TBL] [Abstract][Full Text] [Related]
16. Rationalized Computer-Aided Design of Matrix-Metalloprotease-Selective Prodrugs.
Jain M; Harburn JJ; Gill JH; Loadman PM; Falconer RA; Mooney CA; Cobb SL; Berry DJ
J Med Chem; 2017 May; 60(10):4496-4502. PubMed ID: 28471664
[TBL] [Abstract][Full Text] [Related]
17. Computational Approaches to Matrix Metalloprotease Drug Design.
Singh T; Jayaram B; Adekoya OA
Methods Mol Biol; 2017; 1579():273-285. PubMed ID: 28299743
[TBL] [Abstract][Full Text] [Related]
18. The selectivity of galardin and an azasugar-based hydroxamate compound for human matrix metalloproteases and bacterial metalloproteases.
Sylte I; Dawadi R; Malla N; von Hofsten S; Nguyen TM; Solli AI; Berg E; Adekoya OA; Svineng G; Winberg JO
PLoS One; 2018; 13(8):e0200237. PubMed ID: 30075004
[TBL] [Abstract][Full Text] [Related]
19. Structural bases for substrate and inhibitor recognition by matrix metalloproteinases.
Aureli L; Gioia M; Cerbara I; Monaco S; Fasciglione GF; Marini S; Ascenzi P; Topai A; Coletta M
Curr Med Chem; 2008; 15(22):2192-222. PubMed ID: 18781944
[TBL] [Abstract][Full Text] [Related]
20. Unraveling hidden regulatory sites in structurally homologous metalloproteases.
Udi Y; Fragai M; Grossman M; Mitternacht S; Arad-Yellin R; Calderone V; Melikian M; Toccafondi M; Berezovsky IN; Luchinat C; Sagi I
J Mol Biol; 2013 Jul; 425(13):2330-46. PubMed ID: 23583775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]